[HTML][HTML] Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine

…, ED Ferreri, DL Floda, CR Gleason… - … England Journal of …, 2021 - Mass Medical Soc
Responses of Seropositive Persons to a Single SARS-CoV-2 Vaccine Some persons who
have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 …

[HTML][HTML] SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

…, LQ Eaker, ED Ferreri, DL Floda, CR Gleason… - The Lancet …, 2021 - thelancet.com
It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein, including …

[PDF][PDF] Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma

O Van Oekelen, CR Gleason, S Agte, K Srivastava… - Cancer Cell, 2021 - cell.com
COVID-19 mRNA vaccines are highly efficacious in preventing COVID-19 morbidity and
mortality in phase 3 clinical studies as well as in real-world settings. Emerging evidence …

[PDF][PDF] Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma

…, B Upadhyaya, K Tuballes, K Kappes, CR Gleason… - Cancer Cell, 2021 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines have been proven
to be highly effective at preventing severe disease and mortality in healthy individuals; …

Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects

RH Barbhaiya, ST Forgue, CR Gleason… - Antimicrobial agents …, 1992 - Am Soc Microbiol
The pharmacokinetics of cefepime in 31 young, healthy volunteers were assessed after the
administration of single and multiple 250-, 500-, 1,000-, or 2,000-mg intravenous doses. …

[PDF][PDF] Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients

…, K Serebryakova, S Agte, K Kappes, CR Gleason… - Cancer Cell, 2022 - cell.com
Despite the efficacy of COVID-19 vaccines in healthy individuals, multiple myeloma (MM)
patients are immunocompromised and mount suboptimal humoral and cellular responses after …

[PDF][PDF] Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer

…, S Lee, A Raskin, K Srivastava, CR Gleason… - Cancer Cell, 2022 - cell.com
During the global pandemic with COVID-19, early reports indicated that cancer patients in
general, and lung cancer patients in particular, who were infected with SARS-CoV-2 had high …

Correlation between renal membrane binding and nephrotoxicity of aminoglycosides

PD Williams, DB Bennett, CR Gleason… - Antimicrobial agents …, 1987 - Am Soc Microbiol
The kinetics of aminoglycoside binding to renal brush border and basolateral membrane
vesicles from rat renal cortex were studied by using [3H]amikacin. [3H]amikacin binding to renal …

Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses

RH Barbhaiya, ST Forgue, CR Gleason… - Antimicrobial agents …, 1990 - Am Soc Microbiol
In this double-blind, single-dose phase I study, the safety and tolerance of cefepime were
assessed in 24 healthy male subjects, with ceftazidime as the control drug. Four subjects in …

Novel probabilistic method for precisely correcting the QT interval for heart rate in telemetered dogs and cynomolgus monkeys

HH Holzgrefe, I Cavero, CR Gleason… - … of Pharmacological and …, 2007 - Elsevier
INTRODUCTION:: QT intervals are not regulated on a beat-to-beat cadence, but are strongly
influenced by the preceding heart rate history (hysteresis). ECG sampling, when performed …